Skip to content
healthcare.dev

Voriconazole

NDC 72843-441, voriconazole, injection, powder, lyophilized, for solution, from UBI Pharma Inc..

Product NDC
72843-441
Status
Listed
Labeler
UBI Pharma Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211264
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72843-441 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VORICONAZOLE10 mg/mL

Pharmacologic classes

Azole Antifungal [EPC]; Azoles [CS]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
72843-441-017284304410120 mL in 1 VIAL, SINGLE-USE (72843-441-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9a81e485-7f26-45b6-bfd7-6114afb7def9

Use it

Look up 72843-441 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72843-441 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72843-441. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.